NCI SBIR Program Announcements:
RFA-CA-15-010 SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics and Prognostics Toward Commercialization (R44)
Application receipt date: May 13, 2015
PAR-14-088. Direct Phase II SBIR Grants to Support Biomedical Technology Development
Application receipt dates: September 8, 2015; January 5; 2016; April 5, 2016; September 5, 2016; January 5, 2017
PA-13-140 Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)
Application receipt dates: September 8, 2015; January 5, 2016
PAR-13-327 Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR-IMAT) (R43/R44)
Application receipt dates: May 27, 2015; November 4, 2015; May 27, 2016
For more information about this program, please click here.
Please visit this page often to view new opportunities. You may also sign up to receive email updates from the NCI SBIR Development Center announcing new funding opportunities. If you would like to receive updates from the NCI SBIR and STTR Program, please enter your email address into the box below.